IgA nephropathy and IgA vasculitis in a pediatric Crohn’s disease patient with early IgA deposition in vascular walls of intestines

Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr. 2015;169:1053–60.

Article  PubMed  PubMed Central  Google Scholar 

Oliveira SB, Monteiro IM. Diagnosis and management of inflammatory bowel disease in children. BMJ (Clinical research ed.). 2017;357:j2083.

Dolinger M, Torres J, Vermeire S. Crohn’s disease. Lancet. 2024;403:1177–91.

Article  CAS  PubMed  Google Scholar 

Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161:1118–32.

Article  CAS  PubMed  Google Scholar 

Shield DE, Lytton B, Weiss RM, et al. Urologic complications of inflammatory bowel disease. J Urol. 1976;115:701–6.

Article  CAS  PubMed  Google Scholar 

Mutalib M. Renal involvement in pediatric inflammatory bowel disease. Pediatr Nephrol. 2021;36:279–85.

Article  PubMed  Google Scholar 

Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006;12:4819–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol. 2021;12: 771619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leung AKC, Barankin B, Leong KF. Henoch-Schönlein purpura in children: an updated review. Curr Pediatr Rev. 2020;16:265–76.

Article  PubMed  Google Scholar 

Xu L, Li Y, Wu X. IgA vasculitis update: epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022;13: 921864.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stamellou E, Seikrit C, Tang SCW, et al. IgA nephropathy. Nat Rev Dis Primers. 2023;9:67.

Article  PubMed  Google Scholar 

Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368:2402–14.

Article  CAS  PubMed  Google Scholar 

Willey CJ, Coppo R, Schaefer F, et al. The incidence and prevalence of IgA nephropathy in Europe. Nephrol Dial Transplant. 2023;38:2340–9.

Article  PubMed  PubMed Central  Google Scholar 

Shibano T, Takagi N, Maekawa K, et al. Epidemiological survey and clinical investigation of pediatric IgA nephropathy. Clin Exp Nephrol. 2016;20:111–7.

Article  CAS  PubMed  Google Scholar 

Cheung CK, Barratt J. Further evidence for the mucosal origin of pathogenic IgA in IgA nephropathy. J Am Soc Nephrol. 2022;33:873–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He JW, Zhou XJ, Lv JC, et al. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. Theranostics. 2020;10:11462–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gesualdo L, Di Leo V, Coppo R. The mucosal immune system and IgA nephropathy. Semin Immunopathol. 2021;43:657–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovács T, Kun L, Schmelczer M, et al. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I Study of intestinal permeability. Am J Nephrol. 1996;16:500–5.

Article  PubMed  Google Scholar 

Wyatt J, Vogelsang H, Hübl W, et al. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet. 1993;341:1437–9.

Article  CAS  PubMed  Google Scholar 

Kamei K, Ogura M, Sato M, et al. Evolution of IgA nephropathy into anaphylactoid purpura in six cases–further evidence that IgA nephropathy and Henoch-Schonlein purpura nephritis share common pathogenesis. Pediatr Nephrol. 2016;31:779–85.

Article  PubMed  Google Scholar 

Sy A, Khalidi N, Dehghan N, et al. Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45:475–82.

Article  PubMed  Google Scholar 

Rasmussen C, Abitbol V, El Karoui K, et al. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers. Rheumatology (Oxford). 2022;61:1957–65.

Article  CAS  PubMed  Google Scholar 

Hokama A, Sonosaki T, Zamami R, et al. Crohn disease complicated by IgA vasculitis during therapy with tumor necrosis factor-α inhibitor. Pol Arch Intern Med. 2019;129:283–4.

PubMed  Google Scholar 

Li X, Wang Y, Ge T, et al. Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s disease. Eur J Gastroenterol Hepatol. 2021;33:e1074–5.

Article  CAS  PubMed  Google Scholar 

Marques I, Lagos A, Reis J, et al. Reversible Henoch-Schönlein purpura complicating adalimumab therapy. J Crohns Colitis. 2012;6:796–9.

Article  PubMed  Google Scholar 

Nakayama T, Kaneko H, Okada A, et al. Association of inflammatory Bowel Disease with incident immunoglobulin a nephropathy. Clin J Am Soc Nephrol. 2024;19:704–11.

Article  PubMed  Google Scholar 

Yandian F, Caravaca-Fontán F, Herrera Hernandez LP, et al. Kidney diseases associated with inflammatory Bowel Disease: impact of chronic histologic damage, treatments, and outcomes. Kidney Int Rep. 2023;9:383–94.

Article  PubMed  PubMed Central  Google Scholar 

Graziano F, Busè M, Cassata N, et al. IgA nephropathy in a child: Crohn’s disease-associated or adalimumab induced? Curr Med Res Opin. 2022;38:139–43.

Article  PubMed  Google Scholar 

Terasaka T, Uchida HA, Umebayashi R, et al. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease. BMC Nephrol. 2016;17:122.

Article  PubMed  PubMed Central  Google Scholar 

Choi JY, Yu CH, Jung HY, et al. A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s disease. BMC Nephrol. 2012;13:84.

Article  PubMed  PubMed Central  Google Scholar 

Yang Z, Xu X, Dong Y, et al. The pathological and outcome characteristics of renal lesions in Crohn’s disease. BMC Nephrol. 2022;23:256.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rehnberg J, Symreng A, Ludvigsson JF, et al. Inflammatory Bowel Disease is more common in patients with IgA nephropathy and predicts progression of ESKD: a Swedish population-based Cohort Study. J Am Soc Nephrol. 2021;32:411–23.

Article  CAS  PubMed  Google Scholar 

Knoop T, Vikse BE, Mwakimonga A, et al. Long-term outcome in 145 patients with assumed benign immunoglobulin A nephropathy. Nephrol Dial Transplant. 2017;32:1841–50.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif